Header cover image
  • Investing Ideas
  • Danish Pharmaceuticals & Biotech Healthy potentially undervalued

Danish Pharmaceuticals & Biotech Healthy potentially undervalued

Results

4

1 new

Companies which are potentially undervalued and in an acceptable financial position.

4 companies

Bavarian Nordic

Market Cap: DKK 14.8b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 190.25

7D

-0.03%

1Y

19.7%

H. Lundbeck

Market Cap: DKK 37.2b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 38.70

7D

3.3%

1Y

5.4%

Novo Nordisk

Market Cap: DKK 1.1t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NOVO B

DKK 227.65

7D

-4.1%

1Y

-52.0%

ChemoMetec

Market Cap: DKK 5.2b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

New

CHEMM

DKK 287.20

7D

-27.9%

1Y

-43.7%